Page last updated: 2024-10-31

nocodazole and Amyotrophic Lateral Sclerosis

nocodazole has been researched along with Amyotrophic Lateral Sclerosis in 2 studies

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Watanabe, S1
Inami, H1
Oiwa, K1
Murata, Y1
Sakai, S1
Komine, O1
Sobue, A1
Iguchi, Y1
Katsuno, M1
Yamanaka, K1
Vilmont, V1
Cadot, B1
Vezin, E1
Le Grand, F1
Gomes, ER1

Other Studies

2 other studies available for nocodazole and Amyotrophic Lateral Sclerosis

ArticleYear
Aggresome formation and liquid-liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43.
    Cell death & disease, 2020, 10-23, Volume: 11, Issue:10

    Topics: Amyotrophic Lateral Sclerosis; Animals; DNA-Binding Proteins; HEK293 Cells; HeLa Cells; Histone Deac

2020
Dynein disruption perturbs post-synaptic components and contributes to impaired MuSK clustering at the NMJ: implication in ALS.
    Scientific reports, 2016, 06-10, Volume: 6

    Topics: Agrin; Amyotrophic Lateral Sclerosis; Animals; Cell Differentiation; Cells, Cultured; Disease Models

2016